XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
OPERATING ACTIVITIES      
Net income $ 135,302 $ 92,904  
Adjustments to reconcile net income to net cash (used for) provided by operating activities:      
Depreciation and amortization 25,642 23,878  
Provision for credit losses 1,315 2,813  
Stock-based compensation 23,146 22,673  
Deferred income taxes 15,675 (6,805)  
Excess tax benefit on stock-based compensation (7,032) (1,570)  
Change in loss on disposal group (569) 0  
Other operating activities 6,665 5,596  
Changes in operating elements:      
Receivables (70,602) (225,402)  
Contract assets 2,898 (45,574)  
Prepaid expenses and other (10,994) (11,409)  
Increase (Decrease) in Right of Use Asset 19,315 (13,933)  
Accounts payable and outstanding checks 58,699 84,966  
Accrued compensation (71,579) (23,407)  
Accrued transportation expense (2,071) 38,106  
Accrued income taxes 19,445 3,619  
Other accrued liabilities (12,535) 5,446  
Increase (Decrease) in Operating Lease Liability (26,615) 14,347  
Other assets and liabilities 426 429  
Net cash provided by (used for) operating activities 106,531 (33,323)  
INVESTING ACTIVITIES      
Purchases of property and equipment (3,348) (8,620)  
Purchases and development of software (12,734) (13,854)  
Proceeds from divestiture 27,737 0  
Net cash provided by (used for) investing activities 11,655 (22,474)  
FINANCING ACTIVITIES      
Proceeds from stock issued for employee benefit plans 16,808 5,405  
Stock tendered for payment of withholding taxes (49,829) (16,130)  
Repurchase of common stock (47,700) 0  
Cash dividends (77,490) (74,580)  
Proceeds from short-term borrowings 682,000 912,000  
Payments on short-term borrowings (670,000) (792,000)  
Net cash (used for) provided by financing activities (146,211) 34,695  
Effect of exchange rates on cash and cash equivalents 1,429 (2,584)  
Net change in cash and cash equivalents, including cash and cash equivalents classified within assets held for sale (26,596) (23,686)  
Plus: net decrease in cash and cash equivalents within assets held for sale 10,776 0  
Cash and cash equivalents, beginning of period 145,762 145,524 $ 145,524
Cash and cash equivalents, end of period $ 129,942 $ 121,838 $ 145,762